关于快速起作用抗抑郁药在双极性抑郁症中的作用的现有证据:一个前景和行动计划
相关实验视频
Updated: May 23, 2025

04:44
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
153
Jonathan Repple1, Maximilian Bayas2, Chiara Möser2
1Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital, Goethe University Frankfurt, Frankfurt, Germany; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
Biological psychiatry
|March 10, 2025
概括
快速起作用的抗抑郁药 (RAADs) 对双极性抑郁症有希望,但研究有限. 胺是有效的,但需要对其他RAAD进行更多的研究,以改善治疗选择.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统抑郁症治疗的有限进展刺激了人们对新型抗抑郁药的兴趣.
- 双极性抑郁症研究落后于单极性抑郁症,特别是在快速起作用抗抑郁药 (RAAD) 方面.
- (Es) 胺在双极性抑郁症中显示出有效性和安全性,但对其他RAAD的研究很少.
研究的目的:
- 审查对快速起作用抗抑郁药 (RAADs) 治疗双极性抑郁症的最新进展.
- 提供已发表和正在进行的临床研究 (II-IV期) 关于双相抑郁症RAAD的概述.
- 突出进一步研究新型药物治疗双极性抑郁症的需要.
主要方法:
- 对二极性抑郁症RAADs发表的研究的综述.
- 来自ClinicalTrials.gov的临床试验数据 (II,III,IV阶段) 对双相抑郁症治疗的分析.
- 根据作用机制对研究的RAAD进行分类.
主要成果:
- 几种类型的RAAD正在对双极性抑郁症进行研究,包括NMDA对抗剂,GABA激活剂,迷幻药,肌肉蛋白受体对抗剂和卡帕阿片类受体对抗剂.
- 胺是双极性抑郁症最受研究的RAAD,证明了已确定的疗效和安全性.
- 除了 (es) ketamine之外,对双极性抑郁症的RAADs的研究工作有限,这表明该领域存在差距.
结论:
- 最近对RAAD的研究表明,这是一种治疗双极性抑郁症的新机制.
- 迫切需要对双极性抑郁症中各种RAAD进行精心控制的临床研究.
- 通过RAAD研究扩大治疗选择对于改善双极性抑郁症的结果至关重要.
相关概念视频
Mania and Antimanic Drugs: Overview
106
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
106
Antidepressant Drugs: MAOIs and Other Agents
175
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
175
Psychosis: Goals of Pharmacotherapy
101
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
101
Antidepressant Drugs: Overview
346
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
346
Bipolar Disorder
41
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
41
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
271
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
271

